Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
44.28
-0.28 (-0.63%)
At close: Apr 3, 2025, 4:00 PM
44.37
+0.09 (0.20%)
After-hours: Apr 3, 2025, 7:55 PM EDT
Exact Sciences Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Exact Sciences stock have an average target of 70.59, with a low estimate of 52 and a high estimate of 90. The average target predicts an increase of 59.42% from the current stock price of 44.28.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exact Sciences stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 10 | 11 | 10 | 10 | 10 | 10 |
Buy | 6 | 5 | 6 | 6 | 6 | 6 |
Hold | 1 | 1 | 1 | 1 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 17 | 17 | 17 | 18 | 18 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Hold Initiates $52 | Hold | Initiates | $52 | +17.43% | Mar 13, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $75 → $70 | Buy | Maintains | $75 → $70 | +58.08% | Feb 26, 2025 |
Scotiabank | Scotiabank | Buy Maintains $70 → $73 | Buy | Maintains | $70 → $73 | +64.86% | Feb 24, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $72 → $65 | Strong Buy | Maintains | $72 → $65 | +46.79% | Feb 20, 2025 |
Barclays | Barclays | Buy Maintains $70 → $65 | Buy | Maintains | $70 → $65 | +46.79% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
3.12B
from 2.76B
Increased by 12.98%
Revenue Next Year
3.52B
from 3.12B
Increased by 12.96%
EPS This Year
-0.42
from -5.59
EPS Next Year
0.60
from -0.42
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.2B | 3.7B | 4.2B | ||
Avg | 3.1B | 3.5B | 3.9B | ||
Low | 3.0B | 3.3B | 3.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 16.9% | 19.8% | 18.6% | ||
Avg | 13.0% | 13.0% | 11.5% | ||
Low | 8.0% | 5.7% | 0.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.81 | 2.05 | 3.49 | ||
Avg | -0.42 | 0.60 | 1.50 | ||
Low | -2.15 | -0.07 | 0.70 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | 481.7% | ||
Avg | - | - | 151.1% | ||
Low | - | - | 16.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.